Abstract
Background/Aims: Gastric adenocarcinoma of fundic gland type (GAFG), which is a rare variant of gastric cancer, is reportedly associated with both Wnt/β-catenin signaling activation and guanine nucleotide binding protein, alpha stimulating complex (GNAS) mutations. This study aimed to elucidate potential roles of the Sonic hedgehog (Shh) signaling pathway in GAFG. Methods: We performed immunostaining for β-catenin and Shh signal-associated proteins, including Patched (Ptch), Smoothened (Smo), and Glioma-associated oncogene-1 (Gli1), and the direct sequencing of GNAS/BRAF/KRAS in 27 GAFGs, and compared them with 30 conventional gastric adenocarcinomas (CGAs). Results: GAFGs exhibited significantly lower immunoreactivity scores for Ptch, Smo, and Gli1 than CGAs. Moreover, while the Ptch score was significantly lower in the GAFG tumor areas than in the non-neoplastic areas adjacent to GAFG, the score was significantly higher in the CGA tumor areas than in the non-neoplastic areas. Similar trends were observed in the scores for Smo and Gli1. β-Catenin expression and GNAS mutations were found in 22 (81%) and 8 (30%) of the 27 GAFGs respectively. Gli1 expression was significantly associated with mutations in GNAS. Conclusion: GAFG and CGA exhibited distinct Ptch, Smo, and Gli1 expression patterns. Downregulation of the Shh signaling pathway, as well as activation of the Wnt/β-catenin signaling pathway, may therefore be associated with tumorigenesis in GAFG.
References
1.
Ueyama H, Yao T, Nakashima Y, Hirakawa K, Oshiro Y, Hirahashi M, Iwashita A, Watanabe S: Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol 2010;34:609-619.
[PubMed]
2.
Tsukamoto T, Yokoi T, Maruta S, Kitamura M, Yamamoto T, Ban H, Tatematsu M: Gastric adenocarcinoma with chief cell differentiation. Pathol Int 2007;57:517-522.
[PubMed]
3.
Singhi AD, Lazenby AJ, Montgomery EA: Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma. Am J Surg Pathol 2012;36:1030-1035.
[PubMed]
4.
Chen WC, Rodriguez-Waitkus PM, Barroso A, Balsaver A, McKechnie JC: A rare case of gastric fundic gland adenocarcinoma (chief cell predominant type). J Gastrointest Cancer 2012;43(suppl 1):S262-S265.
[PubMed]
5.
Hidaka Y, Mitomi H, Saito T, Takahashi M, Lee SY, Matsumoto K, Yao T, Watanabe S: Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type. Hum Pathol 2013;44:2438-2448.
[PubMed]
6.
Lee SY, Saito T, Mitomi H, Hidaka Y, Murakami T, Nomura R, Watanabe S, Yao T: Mutation spectrum in the Wnt/β-catenin signaling pathway in gastric fundic gland-associated neoplasms/polyps. Virchows Arch 2015;467:27-38.
[PubMed]
7.
Kushima R, Sekine S, Matsubara A, Taniguchi H, Ikegami M, Tsuda H: Gastric adenocarcinoma of the fundic gland type shares common genetic and phenotypic features with pyloric gland adenoma. Pathol Int 2013;63:318-325.
[PubMed]
8.
Nomura R, Saito T, Mitomi H, Hidaka Y, Lee SY, Watanabe S, Yao T: GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type. Hum Pathol 2014;45:2488-2496.
[PubMed]
9.
Lum L, Beachy PA: The Hedgehog response network: sensors, switches, and routers. Science 2004;304:1755-1759.
[PubMed]
10.
Hooper JE, Scott MP: Communicating with Hedgehogs. Nat Rev Mol Cell Biol 2005;6:306-317.
[PubMed]
11.
Pasca di Magliano M, Hebrok M: Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 2003;3:903-911.
[PubMed]
12.
Schnorrer F, Dickson BJ: Axon guidance: morphogens show the way. Curr Biol 2004;14:R19-R21.
[PubMed]
13.
Taipale J, Beachy PA: The Hedgehog and Wnt signalling pathways in cancer. Nature 2001;411:349-354.
[PubMed]
14.
Ma X, Chen K, Huang S, Zhang X, Adegboyega PA, Evers BM, Zhang H, Xie J: Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis 2005;26:1698-1705.
[PubMed]
15.
Ma XL, Sun HJ, Wang YS, Huang SH, Xie JW, Zhang HW: Study of Sonic hedgehog signaling pathway related molecules in gastric carcinoma. World J Gastroenterol 2006;12:3965-3969.
[PubMed]
16.
Fukaya M, Isohata N, Ohta H, Aoyagi K, Ochiya T, Saeki N, Yanagihara K, Nakanishi Y, Taniguchi H, Sakamoto H, Shimoda T, Nimura Y, Yoshida T, Sasaki H: Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer. Gastroenterology 2006;131:14-29.
[PubMed]
17.
Wang LH, Choi YL, Hua XY, Shin YK, Song YJ, Youn SJ, Yun HY, Park SM, Kim WJ, Kim HJ, Choi JS, Kim SH: Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions. Mod Pathol 2006;19:675-683.
[PubMed]
18.
Saze Z, Terashima M, Kogure M, Ohsuka F, Suzuki H, Gotoh M: Activation of the sonic hedgehog pathway and its prognostic impact in patients with gastric cancer. Dig Surg 2012;29:115-123.
[PubMed]
19.
Lauwers GY, Carneiro F, Graham DY: Gastric carcinoma; in Bosman FT, Carneiro F, Hruban RH, Theise ND (eds): WHO Classification of Tumours of the Digestive System, ed 4. Lyon, IARC Press, 2010, pp 48-58.
20.
He HC, Chen JH, Chen XB, Qin GQ, Cai C, Liang YX, Han ZD, Dai QS, Chen YR, Zeng GH, Zhu JG, Jiang FN, Zhong WD: Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome. Pathol Oncol Res 2012;18:349-355.
[PubMed]
21.
Miki K: Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - “ABC method”. Proc Jpn Acad Ser B Phys Biol Sci 2011;87:405-414.
[PubMed]
22.
Ueyama H, Matsumoto K, Nagahara A, Hayashi T, Yao T, Watanabe S: Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy 2014;46:153-157.
[PubMed]
23.
Miyazawa M, Matsuda M, Yano M, Hara Y, Arihara F, Horita Y, Matsuda K, Sakai A, Noda Y: Gastric adenocarcinoma of fundic gland type: five cases treated with endoscopic resection. World J Gastroenterol 2015;21:8208-8214.
[PubMed]
24.
Kudo T, Kakizaki S, Sohara N, Onozato Y, Okamura S, Inui Y, Mori M: Analysis of ABC (D) stratification for screening patients with gastric cancer. World J Gastroenterol 2011;17:4793-4798.
[PubMed]
25.
Yamaguchi Y, Nagata Y, Hiratsuka R, Kawase Y, Tominaga T, Takeuchi S, Sakagami S, Ishida S: Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - the ABC method. Digestion 2016;93:13-18.
[PubMed]
26.
Lee SY, Han HS, Lee KY, Hwang TS, Kim JH, Sung IK, Park HS, Jin CJ, Choi KW: Sonic hedgehog expression in gastric cancer and gastric adenoma. Oncol Rep 2007;17:1051-1055.
[PubMed]
27.
Faller G, Kirchner T: Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Arch 2005;446:1-9.
[PubMed]
28.
van den Brink GR, Hardwick JC, Tytgat GN, Brink MA, Ten Kate FJ, Van Deventer SJ, Peppelenbosch MP: Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology 2001;121:317-328.
[PubMed]
29.
Heemskerk J, DiNardo S: Drosophila hedgehog acts as a morphogen in cellular patterning. Cell 1994;76:449-460.
[PubMed]
30.
Silva-Vargas V, Lo Celso C, Giangreco A, Ofstad T, Prowse DM, Braun KM, Watt FM: Beta-catenin and Hedgehog signal strength can specify number and location of hair follicles in adult epidermis without recruitment of bulge stem cells. Dev Cell 2005;9:121-131.
[PubMed]
31.
Noramly S, Freeman A, Morgan BA: Beta-catenin signaling can initiate feather bud development. Development 1999;126:3509-3521.
[PubMed]
32.
Iwatsuki K, Liu HX, Grónder A, Singer MA, Lane TF, Grosschedl R, Mistretta CM, Margolskee RF: Wnt signaling interacts with Shh to regulate taste papilla development. Proc Natl Acad Sci U S A 2007;104:2253-2258.
[PubMed]
33.
Yanai K, Nakamura M, Akiyoshi T, Nagai S, Wada J, Koga K, Noshiro H, Nagai E, Tsuneyoshi M, Tanaka M, Katano M: Crosstalk of hedgehog and Wnt pathways in gastric cancer. Cancer Lett 2008;263:145-156.
[PubMed]
34.
Miyazawa K, Iwaya K, Kuroda M, Harada M, Serizawa H, Koyanagi Y, Sato Y, Mizokami Y, Matsuoka T, Mukai K: Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: correlation with early tumor invasion. Virchows Arch 2000;437:508-513.
[PubMed]
35.
Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L: GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989;340:692-696.
[PubMed]
36.
Lyons J, Landis CA, Harsh G, Vallar L, Grünewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, McCormick F: Two G protein oncogenes in human endocrine tumors. Science 1990;249:655-659.
[PubMed]
37.
Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, Eshleman JR, Goggins M, Canto MI, Schulick RD, Edil BH, Wolfgang CL, Klein AP, Diaz LA Jr, Allen PJ, Schmidt CM, Kinzler KW, Papadopoulos N, Hruban RH, Vogelstein B: Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 2011;3:92ra66.
[PubMed]
38.
Furukawa T, Kuboki Y, Tanji E, Yoshida S, Hatori T, Yamamoto M, Shibata N, Shimizu K, Kamatani N, Shiratori K: Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 2011;1:161.
[PubMed]
39.
Amato E, Molin MD, Mafficini A, Yu J, Malleo G, Rusev B, Fassan M, Antonello D, Sadakari Y, Castelli P, Zamboni G, Maitra A, Salvia R, Hruban RH, Bassi C, Capelli P, Lawlor RT, Goggins M, Scarpa A: Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol 2014;233:217-227.
[PubMed]
40.
Carter JM, Inwards CY, Jin L, Evers B, Wenger DE, Oliveira AM, Fritchie KJ: Activating GNAS mutations in parosteal osteosarcoma. Am J Surg Pathol 2014;38:402-409.
[PubMed]
41.
Matsubara A, Sekine S, Kushima R, Ogawa R, Taniguchi H, Tsuda H, Kanai Y: Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol 2013;229:579-587.
[PubMed]
42.
Wilson CH, McIntyre RE, Arends MJ, Adams DJ: The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways. Oncogene 2010;29:4567-4575.
[PubMed]
43.
Regard JB, Malhotra D, Gvozdenovic-Jeremic J, Josey M, Chen M, Weinstein LS, Lu J, Shore EM, Kaplan FS, Yang Y: Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification. Nat Med 2013;19:1505-1512.
[PubMed]
© 2017 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2017
You do not currently have access to this content.
